Synchrony Partners with the Independent Animal Hospital Association (IAHA) to offer CareCredit, Spotlighting Commitment to the Nation's Independent Veterinary Hospitals
STAMFORD, Conn., May 20, 2025 /PRNewswire/ -- Synchrony (NYSE: SYF), a leading consumer financial services company, today announced a partnership with the Independent Animal Hospital Association (IAHA), becoming their preferred financing partner. The IAHA will offer Synchrony's CareCredit health and wellness credit card at the association's more than 500 independent animal hospitals in more than 30 states.
This Small Business Month, Synchrony shines a light on its ongoing commitment to empower independent veterinary practices, understanding the vital role these independent practices play in the veterinary profession. Acceptance of CareCredit offers these practices a flexible financing solution, dedicated support, and valuable resources designed to help address their business needs, foster client loyalty, and ensure long-term growth while expanding access to care for pet owners.
IAHA can now offer its members access to financing through CareCredit, including shorter- and longer-term options, allowing their clients to better budget for their pet's care. By offering CareCredit, IAHA veterinarians can focus on delivering the highest level of care knowing they are providing clients with greater financial flexibility.
"By understanding the unique challenges and opportunities faced by independent animal hospitals and veterinary practices, we're able to provide payment solutions that empower them to meet their clients' needs," said Jonathan Wainberg, Senior Vice President and General Manager, Pet, Synchrony. "Our dedication is evident in our prioritization of partnerships with these vital small businesses, and we're proud to note that they comprise nearly 65% of our veterinary partners."
"The rising costs of veterinary medicine can often place a significant financial burden on pet owners, making it difficult to afford essential care," said Brent Dunbar, President of Independent Animal Hospital Association. "Teaming up with CareCredit to bring pet owners flexible financing options makes it easier for our members to help our clients get their pets the care they deserve."
Pet owners can see if they prequalify for the CareCredit credit card in real time, with no impact to their credit score, and apply on any smart device or apply over the phone. A credit decision is typically provided within a few seconds, and if approved, they can use their account to pay for their pet's care right away. This flexibility helps pet owners to provide the necessary care for their pets, from routine check-ups to emergency treatments.
For more than 35 years, CareCredit has been a valuable financing option for all types of veterinary services, treatments, and diagnostics at locations in the network, giving pet owners peace of mind that they are ready to care for their pets throughout their lifetime. CareCredit is accepted at more than 27,000 veterinary practices and all public university veterinary schools in the U.S. For more information, please visit www.carecredit.com.
About SynchronySynchrony (NYSE: SYF) is a leading consumer financing company at the heart of American commerce and opportunity. From health to home, auto to retail, our Synchrony products have been serving the needs of people and businesses for nearly 100 years. We provide responsible access to credit and banking products to support healthier financial lives for tens of millions of people, enabling them to access the things that matter to them. Additionally, through our innovative products and experiences, we support the growth and operations of some of the country's most respected brands, as well as more than 400,000 small and midsize businesses and health and wellness providers that Americans rely on. Synchrony is proud to be ranked as the country's #2 Best Company to Work For® by Fortune magazine and Great Place to Work®. For more information, visit www.synchrony.com.
About Independent Animal Hospital Association Independent Animal Hospital Association (IAHA) is dedicated to helping independent animal hospitals regain their competitive advantage in a market dominated by corporate medicine. We consist of over 500 independent animal hospitals in over 30 states. For far too long, corporate medicine has enjoyed advantages not available to private practices. Members receive access to exclusive discounts, rebates, programs, and offers all resulting in measurable financial benefits.
Contacts:
Lauren DevilbissSynchronyLauren.Devilbiss@syf.com
Brent DunbarIndependent Animal Hospital Association independentaha@gmail.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/synchrony-partners-with-the-independent-animal-hospital-association-iaha-to-offer-carecredit-spotlighting-commitment-to-the-nations-independent-veterinary-hospitals-302459210.html
SOURCE Synchrony
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Dycom (DY) Reports Q2: Everything You Need To Know Ahead Of Earnings
Telecommunications company Dycom (NYSE:DY) will be reporting earnings this Wednesday before the bell. Here's what to expect. Dycom beat analysts' revenue expectations by 5.7% last quarter, reporting revenues of $1.26 billion, up 10.2% year on year. It was an exceptional quarter for the company, with a beat of analysts' EPS estimates and an impressive beat of analysts' EBITDA estimates. Is Dycom a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Dycom's revenue to grow 17.5% year on year to $1.41 billion, improving from the 15.5% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $2.92 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Dycom has missed Wall Street's revenue estimates twice over the last two years. Looking at Dycom's peers in the engineering and design services segment, some have already reported their Q2 results, giving us a hint as to what we can expect. EMCOR delivered year-on-year revenue growth of 17.4%, beating analysts' expectations by 4.9%, and Sterling reported revenues up 5.4%, topping estimates by 10.8%. EMCOR traded down 2.3% following the results while Sterling was up 8.9%. Read our full analysis of EMCOR's results here and Sterling's results here. There has been positive sentiment among investors in the engineering and design services segment, with share prices up 4.8% on average over the last month. Dycom is up 6.5% during the same time and is heading into earnings with an average analyst price target of $278 (compared to the current share price of $273.50). When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we've found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19 minutes ago
- Yahoo
What To Expect From Target's (TGT) Q2 Earnings
General merchandise retailer Target (NYSE:TGT) will be announcing earnings results this Wednesday morning. Here's what to look for. Target missed analysts' revenue expectations by 2% last quarter, reporting revenues of $23.85 billion, down 2.8% year on year. It was a disappointing quarter for the company, with full-year EPS guidance missing analysts' expectations significantly and a significant miss of analysts' EBITDA estimates. Is Target a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Target's revenue to decline 2.2% year on year to $24.89 billion, a reversal from the 2.7% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $2.04 per share. Heading into earnings, analysts covering the company have grown increasingly bearish with revenue estimates seeing 9 downward revisions over the last 30 days (we track 24 analysts). Target has missed Wall Street's revenue estimates four times over the last two years. Looking at Target's peers in the non-discretionary retail segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Sprouts delivered year-on-year revenue growth of 17.3%, beating analysts' expectations by 2.3%, and Grocery Outlet reported revenues up 4.5%, falling short of estimates by 0.6%. Sprouts traded down 4.1% following the results while Grocery Outlet was up 42.9%. Read our full analysis of Sprouts's results here and Grocery Outlet's results here. There has been positive sentiment among investors in the non-discretionary retail segment, with share prices up 6.4% on average over the last month. Target is up 3.4% during the same time and is heading into earnings with an average analyst price target of $103.69 (compared to the current share price of $105.14). When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we've found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
UBS Raises Price Target for Berkshire Hathaway (BRK-B), Keeps Buy Rating
Berkshire Hathaway Inc. (NYSE:BRK-B) is one of the 9 Best NYSE Stocks to Buy According to Hedge Funds. On August 4, UBS increased its price target on Berkshire Hathaway Inc. (NYSE:BRK-B) from $595 to $597 and kept its Buy rating. This decision came after Berkshire Hathaway Inc. (NYSE:BRK-B) reported operating results for the second quarter of 2025. Skyscrapers with background of graphs and arrows The firm's analyst noted that GEICO, Berkshire Hathaway Inc.'s (NYSE:BRK-B) auto insurance subsidiary, continues to grow and maintain very attractive underlying margins. However, UBS pointed out that there is uncertainty about tariffs and the 'Big Beautiful Bill,' which could affect federal energy tax policies and the tax rate for Berkshire Hathaway Energy Company. Berkshire Hathaway Inc. (NYSE:BRK-B) is an American multinational company led by Warren Buffett. The company and its subsidiaries engage in a wide variety of business activities including insurance and reinsurance, utilities and energy, freight rail transportation, manufacturing, services, and retailing. While we acknowledge the potential of BRK-B as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Best Revenue Growth Stocks to Buy Now and 14 Best Aggressive Growth Stocks to Buy According to Analysts. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
